Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2010
12/02/2010WO2010135972A1 Preparation methods and uses of 1-(substituted aryl)-5-trifluoromethyl-2-(1h)-pyridone compounds and their salts
12/02/2010WO2010135908A1 N-(2-amino-4-pyridyl) benzamide derivatives and uses thereof
12/02/2010WO2010057028A3 Treatment of proteinopathies using a farnesyl transferase inhibitor
12/02/2010US20100305204 Composition useful for the prevention of adverse effect due to the use of ppar-gamma agonists
12/02/2010US20100305191 Rna interference mediated inhibition of adenosine a1 receptor (adora1) gene expression using short interfering rna
12/02/2010US20100305186 Methods for mediating gene suppression
12/02/2010US20100305179 Oral sustained-release tablet
12/02/2010US20100305114 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues
12/02/2010US20100305107 Quinoline derivatives and their use as 5-ht6 ligands
12/02/2010US20100305104 Oxadiazole Diaryl Compounds
12/02/2010US20100305078 Metallo-oxidoreductase inhibitors using metal binding moieties in combination with targeting moieties
12/02/2010US20100305051 Natriuretic activities
12/02/2010US20100305034 Growth factor isoform
12/02/2010US20100305033 Hydroxyalkyl starch derivatives and process for their preparation
12/02/2010US20100303913 Method for Nanoencapsulation
12/02/2010US20100303892 Transdermal therapeutic system containing elongate hollow bodies
12/02/2010US20100303889 Compositions and Methods for Promoting Patency of Vascular Grafts
12/02/2010US20100303886 Graft materials and methods for staged delivery of bioactive components
12/02/2010US20100303884 Growth factor complexes and modulation of cell migration and growth
12/02/2010US20100303837 Carbohydrate specific cellular immunity inducing microorganisms and fractions thereof
12/02/2010US20100303820 Methods of treatment using il-17e antagonists
12/02/2010US20100303799 Treatment of Conditions Related to Shock
12/02/2010US20100303777 Delivery of binding molecules to induce immunomodulation
12/02/2010US20100303776 Methods and compositions for regulated expression of multiple nucleic acids
12/02/2010US20100303740 Process for producing (3s)-i-menthyl 3-hydroxybutyrate and sensate composition
12/02/2010US20100303724 Polypeptides, Cyclic Polypeptides and Pharmaceutical Comprising Thereof for Non Invasive Specific Imaging of Fibrosis
12/02/2010CA2762620A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010CA2761639A1 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
12/02/2010CA2761597A1 Anti-shock agent comprising diaminotrifluoromethylpyridine derivative
12/01/2010EP2256202A2 Stimulus-inducible i (kappa)b kinase ikk signalsome
12/01/2010EP2256199A1 Therapeutic uses of BR43X2 soluble receptors
12/01/2010EP2256114A1 Amide derivative and pharmaceutical composition containing the same
12/01/2010EP2256109A1 Apoptosis inhibitor
12/01/2010EP2256105A1 Novel tetrahydroisoquinoline derivative
12/01/2010EP2255830A1 Concomitant drug
12/01/2010EP2255820A1 Use of parasitic biological agents for prevention and control of autoimmune diseases
12/01/2010EP2255815A2 Nutritional Composition
12/01/2010EP2255814A1 Agent for increasing the quantity of hyaluronic acid
12/01/2010EP2255805A1 Deferasirox for the treatment of hereditary hemochromatosis
12/01/2010EP2255801A1 Pharmaceutically active isoindoline derivatives
12/01/2010EP2255667A1 Pasteurisation process for microbial cells and microbial oil
12/01/2010EP2255666A1 Pasteurisation process for microbial cells and microbial oil
12/01/2010EP2254569A1 Protopanaxadiol-type ginsenoside compositions and uses thereof
12/01/2010EP1572077B1 Uses of monoclonal antibody 8h9
12/01/2010EP1487442B1 Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor
12/01/2010EP1372706B1 Proteosome-liposaccharide vaccine adjuvant
12/01/2010EP1322156B3 Disinfectant
12/01/2010EP1244790B1 Nucleic acids encoding polypeptides having chips activity
12/01/2010CN1928112B Expression of VEGF I type receptor on blood vessel adventitia fibroblast
12/01/2010CN1913915B Methods for protecting against radiation using flagellin
12/01/2010CN1902307B Tissue regeneration method
12/01/2010CN1870983B Compositions and foods for improving lipid metabolism
12/01/2010CN1847261B Cyclic peptides as g-protein-coupled receptor antagonists
12/01/2010CN1617703B Composition comprising at least one alkanolamide for inhibiting langerhans cells migration, and uses thereof
12/01/2010CN101903045A Pharmaceutical composition for treatment of cataract
12/01/2010CN101903040A Turkey herpesvirus vectored recombinant containing avian influenza genes
12/01/2010CN101899471A Recombinant retrovirus vector for simultaneously expressing antigen-specific receptor and exogenous gene, B-lymphocyte modified by using same and application thereof
12/01/2010CN101899047A Beta-amino tetrahydropyrazine, tetrahydropyrimidine and tetrahydropyridine used as dipeptidy peptidase inhibitors for curing or preventing diabetes
12/01/2010CN101899039A Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
12/01/2010CN101899001A N-(2-amino-4-pyridyl)-benzamide derivative and application thereof
12/01/2010CN101898982A Npy y5 antagonists
12/01/2010CN101897993A Method of soft tissue augmentation
12/01/2010CN101897969A Use of complement inhibitors in preparing medicines for preventing or treating tissure damage
12/01/2010CN101897951A Anti-inflammatory effect of novel anti-inflammatory molecular DRP, implementation method and application
12/01/2010CN101897950A Antiviral actions, implementation method and use of novel antiviral molecule DRP
12/01/2010CN101897946A Disease-dispelling radix puerariae wine
12/01/2010CN101897921A Liuhe wine
12/01/2010CN101897910A Hidroschesis powder
12/01/2010CN101897907A Chinese medicinal preparation for treating night sweat
12/01/2010CN101897891A Chinese medicinal powder for treating cecidium
12/01/2010CN101897840A Oral Chinese medicinal preparation for treating hydrocele of tunica vaginalis
12/01/2010CN101897778A Medicament for treating night sweat
12/01/2010CN101897774A Blood-nourishing and pulse-adjusting alcohol
12/01/2010CN101897739A Hand anti-venom healing paste
12/01/2010CN101897724A Method for producing a soft tissue filler and method for producing an adipose tissue transplant
12/01/2010CN101897662A Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent
12/01/2010CN101897660A Externally-applied traditional Chinese medicine for treating hernia
12/01/2010CN101897378A Antipyretic tea for removing liver-fire
12/01/2010CN101229185B Medicine compounds for treating seriously disease
12/01/2010CN101066126B Health food suitable for middle aged and old women
11/2010
11/30/2010US7842784 Antagonizing bone morphogenetic protein activity; utilizing polypeptide comprising amino acids 22-452 of sequence 8; bone diseases, tissue regeneration, wound healing
11/30/2010US7842718 thiophene sulfonamide derivatives such as 5-Chloro-N-[(S)-2-hydroxy-1-phenylethyl]thiophene-2-sulfonamide, that inhibit the production of beta amyloid protein from amyloid precursor protein; capable of passing through the blood-brain barrier, used for treatment of Alzheimer's disease and Down's syndrome
11/30/2010US7842706 Pharmaceutical composition
11/30/2010US7842705 Curcumin analogs with anti-tumor and anti-angiogenic properties
11/30/2010US7842701 tyrosine kinase inhibitors such as 3-amino-2-(2-chloro-5-hydroxyphenyl)-7-(3-morpholin-4-ylpropoxy)-2,5-dihydro-4H-pyrazolo[4,3-c]quinolin-4-one, used as anticarcinogenic or antiproliferative agents
11/30/2010US7842699 administering 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile or salts, for the treatment of dermatitis, Crohn's disease, inflammatory bowel disease, transplant rejection, lupus, multiple sclerosis, arthritis, psoriasis, diabetes and autoimmune diseases
11/30/2010US7842683 Beta-lactam antibiotics and beta-lactamase inhibitors provide significant neurotropic effects in warm-blooded vertebrates evidenced inter alia by anxiolytic and antiaggressive behavior modification and enhanced cognition
11/30/2010US7842311 for oral dosage; for treatment of pain; sustained release
11/30/2010US7842309 Tamper-resistant oral opioid agonist formulations
11/30/2010CA2583492C Naphthalene and isoquinoline derivatives bearing a pyridyl group for the treatment of skin lesions
11/30/2010CA2497868C Heterocyclic compounds
11/30/2010CA2482858C Tricyclic thrombin receptor antagonists
11/30/2010CA2477208C Substituted phenylalkanoic acid derivatives and use thereof
11/30/2010CA2460682C Ester compound and medical use thereof
11/30/2010CA2456817C Alkyne-aryl-naphthyridin-4 (1h)-one derivatives as type iv phosphodiesterase inhibitor
11/30/2010CA2440218C Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use as adenosine receptor-selective ligands
11/30/2010CA2295876C Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
11/30/2010CA2193969C Peptide, a method of obtaining it and a pharmaceutical compound based on it
11/25/2010WO2010134595A1 Anti-obesity agent comprising compound containing benzotropolone ring
11/25/2010WO2010134588A1 Method for prediction of therapeutic effect of chemotherapy employing expression level of dihydropyrimidine dehydrogenase gene as measure
1 ... 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 ... 1564